{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 36,
        "end": 42
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 20,
        "end": 25
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 47,
        "end": 56
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 61,
        "end": 65
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 114,
        "end": 146
      }
    },
    {
      "id": "T8",
      "obj": "Disease",
      "span": {
        "begin": 61,
        "end": 85
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 114,
        "end": 173
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 20,
        "end": 35
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "25870087_1",
  "text": "Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR -Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors ."
}
